Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Molecular Metabolism|April 6, 2021
Diabetes mellitus due to toxic misfolding of proinsulin variantsBalamurugan Dhayalan, Deepak Chatterjee, Yen-Shan Chen, et al.
The Journal of Biological Chemistry|August 29, 2002
Sex-specific gene regulation. The Doublesex DM motif is a bipartite DNA-binding domainUma Narendra, Lingyang Zhu, Biaoru Li, et al.
Journal of Diabetes Science and Technology|April 28, 2012
Insulin fibrillation and protein design: topological resistance of single-chain analogs to thermal degradation with application to a pump reservoirNelson B Phillips, Jonathan Whittaker, Faramarz Ismail-Beigi, et al.
The Journal of Biological Chemistry|October 29, 2011
Structural analysis of proinsulin hexamer assembly by hydroxyl radical footprinting and computational modelingJanna G Kiselar, Manish Datt, Mark R Chance, et al.
International Journal of Peptide Research and Therapeutics|January 27, 2025
Synthetic studies of the mutant proinsulin syndrome demonstrate correlation between folding efficiency and age of diabetes onsetBalamurugan Dhayalan, Yen-Shan Chen, Chun-Lun Ni, et al.
Chemical Communications (Cambridge, England)|September 30, 2010
Total chemical synthesis of human proinsulinSamuel Luisier, Michal Avital-Shmilovici, Michael A Weiss, et al.
Annals of the New York Academy of Sciences|May 30, 2012
Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineeringDaniel F Berenson, Allison R Weiss, Zhu-Li Wan, et al.
The Journal of Biological Chemistry|July 9, 2014
Deciphering a molecular mechanism of neonatal diabetes mellitus by the chemical synthesis of a protein diastereomer, [D-AlaB8]human proinsulinMichal Avital-Shmilovici, Jonathan Whittaker, Michael A Weiss, et al.
Journal of Molecular Biology|June 26, 2003
Insulin assembly damps conformational fluctuations: Raman analysis of amide I linewidths in native states and fibrilsJian Dong, Zhuli Wan, Maxim Popov, et al.
Diabetologia|March 12, 2021
'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analoguesMark A Jarosinski, Balamurugan Dhayalan, Nischay Rege, et al.
Pageof 13